Table 5.

Incremental costs, incremental health-related quality of life (QALYs), and cost-effectiveness analysis by level of GFR

CostsQALYsCostsQALYs
GFR ≥ 45 (Intervention n = 79, Control n = 81)GFR < 45 (Intervention n = 159, Control n = 155)
Cost-effectiveness results (disease-related costs)
    intervention$35821.511$49861.446
    control$61851.456$57381.440
    incrementala−$26030.055−$7530.006
Cost-effectiveness results (all costs)
    intervention$10,5981.511$12,2051.446
    control$14,6031.456$14,0841.440
    incrementala−$40050.055−$18800.006
GFR ≥ 40 (Intervention n = 158, Control n = 146)GFR < 40 (Intervention n = 80, Control n = 90)
Cost-effectiveness results (disease-related costs)
    intervention$43891.536$49451.459
    control$53041.498$72331.382
    incrementala−$9150.038−$2,2880.077
Cost-effectiveness results (all costs)
    intervention$11,7611.536$11,3601.459
    control$12,9271.498$16,6641.382
    incrementala−$11660.038−$53040.077
  • a Incremental, intervention minus control.

  • b Less costly, more QALYs.